Health Condition 1: A150- Tuberculosis of lung
Conditions
Interventions
Intervention1: Capsule Probiotic, oral, once daily + Standard Anti-Tubercular Therapy: Capsule Probiotic, oral, once daily, each capsule containing Lactobacillus Acidophilus 1.33 billion CFUs, Lactob
Sponsors
Dr Sandeep Kalaiselvan
Eligibility
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed adult pulmonary TB patients with MTB geneXpert positivity 2. New TB patients with comorbidities T2DM, SHT, if under control
Exclusion criteria
Exclusion criteria: 1. Old patients of TB already under treatment 2. TB patients less than 20 years and more than 65 years of age 3. Pregnant and lactating women 4. TB patients with comorbidities like cancer, HIV and other immunosuppressants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in IL6 levels in the patients receiving probiotics as add-on treatment along with standard ATTTimepoint: At Baseline and at the end of 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in the occurrence of gastrointestinal adverse effects like vomiting and diarrhea in the patients receiving probiotics as add-on treatment along with standard ATTTimepoint: At the end of two months | — |
Countries
India
Contacts
Public ContactSandeep Kalaiselvan
Sri Ramachandra Medical College and Research Institute
Outcome results
None listed